Noticias y eventos de Voyager Acquisition Corp (VACH)

$17.115

-0.183 (-1.07%)Al cierre

Noticias de VACH

VERAXA Completes Merger with Voyager Acquisition Corp.

VERAXA Biotech Secures $27.5 Million Financing Agreement

VERAXA Secures Financing to Advance Cancer Therapies Pipeline

Voyager Acquisition's Merger with Veraxa Biotech Approved

VOYAGER ACQUISITION CORPORATION RECEIVES GREEN LIGHT FOR BUSINESS MERGER WITH VERAXA BIOTECH AG

VERAXA Biotech Merger with Voyager Approved by Shareholders

Shareholder Notice: M&A Class Action Firm Ongoing Investigation into the Merger Involving PBBK, VACH, LCTC, and SMLR

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Voyager Acquisition Corp. (NASDAQ: VACH)

VERAXA Biotech AG to Showcase Novel Cancer Therapies at Upcoming ASCO and BIO International Conventions